$OPK
OPKO HEALTH, INC.

2013 Q3 Form 10-Q Financial Statement

#000094480913000007 Filed on August 09, 2013

View on sec.gov

Income Statement

Concept 2013 Q3 2013 Q2 2012 Q4
Revenue $20.64M $23.82M $16.26M
YoY Change 75.0% 133.29% 180.36%
Cost Of Revenue $11.95M $13.10M $8.900M
YoY Change 59.64% 99.92% 111.9%
Gross Profit $39.65M $41.81M $25.97M
YoY Change 87.36% 113.81% 1523.38%
Gross Profit Margin 192.09% 175.5% 159.73%
Selling, General & Admin $13.57M $13.88M $10.40M
YoY Change 85.36% 155.36% 103.92%
% of Gross Profit 34.23% 33.2% 40.04%
Research & Development $11.09M $9.557M $6.600M
YoY Change 206.13% 112.85% 53.49%
% of Gross Profit 27.96% 22.86% 25.41%
Depreciation & Amortization $3.768M $3.451M $2.800M
YoY Change 41.39% 40.63% 211.11%
% of Gross Profit 9.5% 8.25% 10.78%
Operating Expenses $39.65M $41.81M $17.10M
YoY Change 87.35% 113.81% 69.31%
Operating Profit -$19.01M -$17.98M -$1.039M
YoY Change 97.08% 75.55% -87.78%
Interest Expense -$40.80M $8.900M $900.0K
YoY Change 13500.0% -4550.0% -228.57%
% of Operating Profit
Other Income/Expense, Net -$38.90M $16.93M -$1.100M
YoY Change 32317.5% -6463.16% -375.0%
Pretax Income -$57.91M -$1.057M -$10.00M
YoY Change 510.3% -89.18% 13.64%
Income Tax $1.290M $925.0K -$9.700M
% Of Pretax Income
Net Earnings -$60.00M -$3.394M -$500.0K
YoY Change 522.0% -66.87% -102.72%
Net Earnings / Revenue -290.67% -14.25% -3.07%
Basic Earnings Per Share
Diluted Earnings Per Share -$166.4K -$10.10K -$1.689K
COMMON SHARES
Basic Shares Outstanding 336.8M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q3 2013 Q2 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $180.8M $169.1M $27.40M
YoY Change 326.42% 205.79% -61.68%
Cash & Equivalents $155.8M $119.1M $27.36M
Short-Term Investments $25.00M $50.00M
Other Short-Term Assets $4.304M $19.00M $4.750M
YoY Change -13.92% 363.41% 115.91%
Inventory $19.52M $19.78M $22.26M
Prepaid Expenses
Receivables $21.37M $22.23M $21.16M
Other Receivables $6.800M $0.00 $0.00
Total Short-Term Assets $241.3M $230.1M $78.66M
YoY Change 174.18% 149.31% -21.03%
LONG-TERM ASSETS
Property, Plant & Equipment $17.03M $16.58M $15.71M
YoY Change 33.02% 218.79% 190.83%
Goodwill $222.3M $82.09M $80.45M
YoY Change 102.06%
Intangibles $79.78M $84.24M
YoY Change
Long-Term Investments $23.10M $26.70M $15.60M
YoY Change 54.0% 80.41% 132.84%
Other Assets $7.003M $2.784M $2.777M
YoY Change 268.58% 132.0% 113.62%
Total Long-Term Assets $1.142B $411.0M $211.2M
YoY Change 604.76% 197.37% 62.57%
TOTAL ASSETS
Total Short-Term Assets $241.3M $230.1M $78.66M
Total Long-Term Assets $1.142B $411.0M $211.2M
Total Assets $1.383B $641.1M $289.8M
YoY Change 453.19% 178.13% 26.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.63M $11.65M $10.20M
YoY Change 89.32% 164.68% 108.16%
Accrued Expenses $43.27M $31.05M $24.66M
YoY Change 98.48% 144.45% 393.12%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $14.48M $16.78M $17.53M
YoY Change -16.8% 14.92% 99.16%
Total Short-Term Liabilities $71.38M $59.47M $52.38M
YoY Change 53.83% 87.6% 178.63%
LONG-TERM LIABILITIES
Long-Term Debt $3.350M $188.5M $5.150M
YoY Change -16.25%
Other Long-Term Liabilities $234.8M $80.60M $34.17M
YoY Change 1197.03% 426.82% 83.7%
Total Long-Term Liabilities $443.7M $269.1M $34.17M
YoY Change 1907.6% 1659.0% 83.7%
TOTAL LIABILITIES
Total Short-Term Liabilities $71.38M $59.47M $52.38M
Total Long-Term Liabilities $443.7M $269.1M $34.17M
Total Liabilities $515.1M $328.6M $86.55M
YoY Change 548.69% 501.82% 95.81%
SHAREHOLDERS EQUITY
Retained Earnings -$486.4M -$426.4M -$388.8M
YoY Change
Common Stock $4.089M $3.391M $3.056M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $7.457M $7.457M $7.457M
YoY Change
Treasury Stock Shares 2.293M shares 2.293M shares 2.293M shares
Shareholders Equity $870.7M $314.5M $179.4M
YoY Change
Total Liabilities & Shareholders Equity $1.383B $641.1M $289.8M
YoY Change 453.19% 178.13% 26.29%

Cashflow Statement

Concept 2013 Q3 2013 Q2 2012 Q4
OPERATING ACTIVITIES
Net Income -$60.00M -$3.394M -$500.0K
YoY Change 522.0% -66.87% -102.72%
Depreciation, Depletion And Amortization $3.768M $3.451M $2.800M
YoY Change 41.39% 40.63% 211.11%
Cash From Operating Activities -$8.900M -$6.000M -$5.700M
YoY Change 368.42% -4.76% -13.64%
INVESTING ACTIVITIES
Capital Expenditures -$900.0K -$1.300M -$400.0K
YoY Change 28.57% 550.0% -50.0%
Acquisitions
YoY Change
Other Investing Activities $46.20M -$51.90M $8.800M
YoY Change -557.43% 1106.98% -77.89%
Cash From Investing Activities $45.20M -$53.20M $8.400M
YoY Change -518.52% 1082.22% -78.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 300.0K -3.300M 1.000M
YoY Change -116.67% -273.68% -111.9%
NET CHANGE
Cash From Operating Activities -8.900M -6.000M -5.700M
Cash From Investing Activities 45.20M -53.20M 8.400M
Cash From Financing Activities 300.0K -3.300M 1.000M
Net Change In Cash 36.60M -62.50M 3.700M
YoY Change -352.41% 602.25% -84.71%
FREE CASH FLOW
Cash From Operating Activities -$8.900M -$6.000M -$5.700M
Capital Expenditures -$900.0K -$1.300M -$400.0K
Free Cash Flow -$8.000M -$4.700M -$5.300M
YoY Change 566.67% -22.95% -8.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
11646000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10200000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-602000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2012Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
21636000 USD
CY2013Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
23135000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21162000 USD
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22227000 USD
CY2012Q4 us-gaap Accrued Employee Benefits Current And Noncurrent
AccruedEmployeeBenefitsCurrentAndNoncurrent
3319000 USD
CY2013Q2 us-gaap Accrued Employee Benefits Current And Noncurrent
AccruedEmployeeBenefitsCurrentAndNoncurrent
3972000 USD
CY2013Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2421000 USD
CY2012Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1614000 USD
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
31045000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
24656000 USD
CY2012Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
24656000 USD
CY2013Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
31045000 USD
CY2012Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
675000 USD
CY2013Q2 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
933000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
3196000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
1434000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
7356000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2830000 USD
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
742097000 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
565201000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7003000 USD
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1800000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7000000 USD
CY2012Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1000000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2200000 USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
500000 USD
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
900000 USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
474000 USD
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
908000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
343000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
29701838 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
29910492 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27243783 shares
CY2012Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27416029 shares
CY2012Q4 us-gaap Assets
Assets
289830000 USD
CY2013Q2 us-gaap Assets
Assets
641080000 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
230116000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
78657000 USD
CY2012Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
5335000 USD
CY2013Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
79041000 USD
CY2013Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
26690000 USD
CY2012Q4 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
12148000 USD
CY2013Q2 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
81921000 USD
us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0 USD
us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
10821000 USD
us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
10800000 USD
CY2012Q4 us-gaap Available For Sale Securities Gross Unrealized Gain Loss
AvailableForSaleSecuritiesGrossUnrealizedGainLoss
88000 USD
CY2013Q2 us-gaap Available For Sale Securities Gross Unrealized Gain Loss
AvailableForSaleSecuritiesGrossUnrealizedGainLoss
959000 USD
CY2012Q4 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
0 USD
CY2013Q2 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
7000 USD
CY2012Q4 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
6725000 USD
CY2013Q2 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
1928000 USD
CY2012Q4 us-gaap Business Acquisition Contingent Consideration At Fair Value
BusinessAcquisitionContingentConsiderationAtFairValue
20000000 USD
CY2013Q2 us-gaap Business Acquisition Contingent Consideration At Fair Value
BusinessAcquisitionContingentConsiderationAtFairValue
68900000 USD
CY2012Q4 us-gaap Business Acquisition Contingent Consideration At Fair Value Current
BusinessAcquisitionContingentConsiderationAtFairValueCurrent
5126000 USD
CY2013Q2 us-gaap Business Acquisition Contingent Consideration At Fair Value Current
BusinessAcquisitionContingentConsiderationAtFairValueCurrent
5298000 USD
CY2013Q2 us-gaap Business Acquisition Equity Interest Issued Or Issuable Value Assigned
BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
480000000 USD
us-gaap Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued
BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
0.9951 shares
CY2013Q2 us-gaap Business Acquisition Purchase Price Allocation Current Liabilities Accrued Liabilities
BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesAccruedLiabilities
5300000 USD
CY2013Q2 us-gaap Business Acquisition Purchase Price Allocation Goodwill Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillAmount
364900000 USD
CY2012Q4 us-gaap Business Acquisition Purchase Price Allocation Intangible Assets Other Than Goodwill
BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill
176200000 USD
CY2013Q2 us-gaap Business Acquisition Purchase Price Allocation Other Noncurrent Liabilities
BusinessAcquisitionPurchasePriceAllocationOtherNoncurrentLiabilities
63600000 USD
CY2013Q2 us-gaap Business Acquisition Share Price
BusinessAcquisitionSharePrice
7.00
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset
1300000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
119061000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27361000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38171000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
71516000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-33345000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
91700000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
0 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-82000 USD
CY2011Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1000000 shares
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
305560763 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
339045029 shares
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
3391000 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
3056000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-42555000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6489000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14159000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8657000 USD
CY2013Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
188524000 USD
CY2012Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
24860000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
11541000 USD
CY2012Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6554000 USD
CY2013Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13103000 USD
CY2013Q2 us-gaap Debt Instrument Basis Spread On Variable Rate
DebtInstrumentBasisSpreadOnVariableRate
0.0983
CY2013Q1 us-gaap Debt Instrument Basis Spread On Variable Rate
DebtInstrumentBasisSpreadOnVariableRate
0.0944
CY2013Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
7.07
us-gaap Debt Instrument Convertible Conversion Ratio
DebtInstrumentConvertibleConversionRatio
141.4827 Rate
CY2013Q1 us-gaap Debt Instrument Convertible Conversion Ratio
DebtInstrumentConvertibleConversionRatio
141.4827 Rate
CY2013Q1 us-gaap Debt Instrument Convertible Effective Interest Rate
DebtInstrumentConvertibleEffectiveInterestRate
0.0112
us-gaap Debt Instrument Convertible Effective Interest Rate
DebtInstrumentConvertibleEffectiveInterestRate
0.0157
CY2013Q1 us-gaap Debt Instrument Convertible Stock Price Trigger
DebtInstrumentConvertibleStockPriceTrigger
6.20
us-gaap Debt Instrument Convertible Stock Price Trigger
DebtInstrumentConvertibleStockPriceTrigger
7.10
us-gaap Debt Instrument Convertible Terms Of Conversion Feature
DebtInstrumentConvertibleTermsOfConversionFeature
convertible at any time on or after November 1, 2032, through the second scheduled trading day immediately preceding the maturity date, at the option of the holders
CY2013Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.03
CY2013Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.03
CY2012Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.03
CY2013Q1 us-gaap Debt Instrument Issuance Date1
DebtInstrumentIssuanceDate1
2013-01-30
us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2033-02-01
CY2013Q2 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.042
CY2012Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.045
CY2013Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3903000 USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1518000 USD
CY2013Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
7185000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
9777000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4782000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6880000 USD
CY2012Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2454000 USD
CY2013Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3451000 USD
CY2012Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
23000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1140000 USD
CY2013Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
12651000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-10898000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
56000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-106000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.3847
CY2013Q2 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
108400000 USD
CY2013Q2 us-gaap Equity Method Investment Summarized Financial Information Liabilities
EquityMethodInvestmentSummarizedFinancialInformationLiabilities
33000000 USD
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
-33800000 USD
CY2012Q4 us-gaap Finite Lived Computer Software Gross
FiniteLivedComputerSoftwareGross
52810000 USD
CY2013Q2 us-gaap Finite Lived Computer Software Gross
FiniteLivedComputerSoftwareGross
52796000 USD
CY2012Q4 us-gaap Finite Lived Customer Relationships Gross
FiniteLivedCustomerRelationshipsGross
23088000 USD
CY2013Q2 us-gaap Finite Lived Customer Relationships Gross
FiniteLivedCustomerRelationshipsGross
22839000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
19073000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
14072000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
79775000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
84238000 USD
CY2012Q4 us-gaap Finite Lived Noncompete Agreements Gross
FiniteLivedNoncompeteAgreementsGross
8662000 USD
CY2013Q2 us-gaap Finite Lived Noncompete Agreements Gross
FiniteLivedNoncompeteAgreementsGross
8660000 USD
CY2012Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
9637000 USD
CY2013Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
9690000 USD
CY2012Q4 us-gaap Finite Lived Trade Names Gross
FiniteLivedTradeNamesGross
3746000 USD
CY2013Q2 us-gaap Finite Lived Trade Names Gross
FiniteLivedTradeNamesGross
3683000 USD
CY2013Q2 us-gaap Foreign Currency Derivatives At Fair Value Net
ForeignCurrencyDerivativesAtFairValueNet
2242000 USD
CY2012Q4 us-gaap Foreign Currency Derivatives At Fair Value Net
ForeignCurrencyDerivativesAtFairValueNet
1294000 USD
CY2013Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-2371000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
-6261000 USD
CY2012Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-475000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
-996000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
80450000 USD
CY2013Q2 us-gaap Goodwill
Goodwill
82086000 USD
CY2012Q2 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
145000 USD
CY2013Q2 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
3188000 USD
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
232000 USD
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
6280000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
0 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-943000 USD
us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-1540000 USD
us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
0 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-9768000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-17641000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-31886000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1057000 USD
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
217000 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
925000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
968000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-197000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
242000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
333000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-796000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1652000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2681000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-87000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4591000 USD
us-gaap Increase Decrease In Fair Value Of Unhedged Derivative Instruments
IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments
1140000 USD
us-gaap Increase Decrease In Fair Value Of Unhedged Derivative Instruments
IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments
-10898000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1213000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3321000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-11000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-97000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1318000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2572000 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
84238000 USD
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
79775000 USD
us-gaap Interest And Other Income
InterestAndOtherIncome
547000 USD
CY2013Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
16926000 USD
CY2012Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
-427000 USD
us-gaap Interest And Other Income
InterestAndOtherIncome
-7130000 USD
us-gaap Interest Expense Other
InterestExpenseOther
582000 USD
CY2012Q2 us-gaap Interest Expense Other
InterestExpenseOther
231000 USD
us-gaap Interest Expense Other
InterestExpenseOther
6739000 USD
CY2013Q2 us-gaap Interest Expense Other
InterestExpenseOther
3842000 USD
us-gaap Interest Income Other
InterestIncomeOther
74000 USD
CY2012Q2 us-gaap Interest Income Other
InterestIncomeOther
47000 USD
CY2013Q2 us-gaap Interest Income Other
InterestIncomeOther
90000 USD
us-gaap Interest Income Other
InterestIncomeOther
149000 USD
us-gaap Interest Paid
InterestPaid
318000 USD
us-gaap Interest Paid
InterestPaid
341000 USD
CY2013Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
2275000 USD
CY2012Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
0 USD
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
17963000 USD
CY2013Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
15169000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
22261000 USD
CY2013Q2 us-gaap Inventory Net
InventoryNet
19778000 USD
CY2012Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4923000 USD
CY2013Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
4721000 USD
CY2013Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1365000 USD
CY2012Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1313000 USD
CY2012Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
688000 USD
CY2013Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
1253000 USD
CY2013Q2 us-gaap Liabilities
Liabilities
328596000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
86550000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
289830000 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
641080000 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
59469000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
52382000 USD
CY2012Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
34168000 USD
CY2013Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
269127000 USD
us-gaap License And Services Revenue
LicenseAndServicesRevenue
432000 USD
CY2013Q2 us-gaap License And Services Revenue
LicenseAndServicesRevenue
5203000 USD
us-gaap License And Services Revenue
LicenseAndServicesRevenue
21052000 USD
CY2012Q2 us-gaap License And Services Revenue
LicenseAndServicesRevenue
294000 USD
CY2013Q2 us-gaap Licenses Revenue
LicensesRevenue
2015000 USD
us-gaap Licenses Revenue
LicensesRevenue
14772000 USD
us-gaap Licenses Revenue
LicensesRevenue
200000 USD
CY2012Q2 us-gaap Licenses Revenue
LicensesRevenue
149000 USD
us-gaap Line Of Credit Facility Maximum Amount Outstanding During Period
LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod
19625000 USD
CY2012Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
15195000 USD
CY2013Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
13261000 USD
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
17526000 USD
CY2013Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
16778000 USD
CY2012Q4 us-gaap Long Term Investments
LongTermInvestments
15636000 USD
CY2013Q2 us-gaap Long Term Investments
LongTermInvestments
26690000 USD
CY2013Q2 us-gaap Loss Contingency New Claims Filed Number
LossContingencyNewClaimsFiledNumber
5 Suit
CY2013Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
50027000 USD
CY2012Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0 USD
CY2012Q4 us-gaap Minority Interest
MinorityInterest
-492000 USD
CY2013Q2 us-gaap Minority Interest
MinorityInterest
-1998000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6757000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
166324000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-53848000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22398000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20670000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17760000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-17678000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-20670000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-10245000 USD
us-gaap Net Income Loss
NetIncomeLoss
-37609000 USD
us-gaap Net Income Loss
NetIncomeLoss
-18854000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-3394000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1506000 USD
CY2012Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2013Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-959000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-38029000 USD
CY2012Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10805000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19974000 USD
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3394000 USD
CY2013Q2 us-gaap Notional Amount Of Foreign Currency Derivatives
NotionalAmountOfForeignCurrencyDerivatives
2109000 USD
CY2012Q4 us-gaap Notional Amount Of Foreign Currency Derivatives
NotionalAmountOfForeignCurrencyDerivatives
1304000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segment
us-gaap Operating Expenses
OperatingExpenses
37176000 USD
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
19552000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
41804000 USD
us-gaap Operating Expenses
OperatingExpenses
79953000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-17983000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-9341000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-24756000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-18188000 USD
CY2012Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
6182000 USD
CY2013Q2 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
6496000 USD
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2784000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2777000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1762000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
610000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2085000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-780000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1762000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4526000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeBeforeTax
5900000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeBeforeTax
7500000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
-4593000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
-3602000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
0 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
5205000 USD
CY2012Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
5096000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1829000 USD
CY2013Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
424000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
5402000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
4099000 USD
CY2013Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
2688000 USD
CY2012Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
2108000 USD
CY2012Q4 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
367000 USD
CY2013Q2 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
1180000 USD
CY2013Q2 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
2191000 USD
CY2012Q4 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
380000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
34168000 USD
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
80603000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10358000 USD
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-266000 USD
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8027000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-85000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
0 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
3120000 USD
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
3015000 USD
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
0 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-78000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2173000 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
13341000 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
2700000 USD
CY2011Q3 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
2000000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
50027000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
17117000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
408000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2054000 USD
CY2012Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
560000 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
420000 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1120000 USD
CY2013Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 USD
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19023000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7873000 USD
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassifications.</font><font style="font-family:inherit;font-size:10pt;"> Certain prior year amounts in the condensed consolidated financial statements have been reclassified to conform with the 2013 presentation. Due to the acquisition of OPKO OURLab, LLC (formerly Prost-Data, Inc.), our CLIA-certified laboratory business (&#8220;OURLab&#8221;) in December 2012, we changed our segment presentation to include diagnostics as a reportable segment. As a result of this change in reportable segments, we restated certain prior year amounts in the condensed consolidated financial statements to conform with the 2013 presentation. These reclassifications had no impact on our results of operations. </font></div></div>
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
170184000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1519000 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1492000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
15354000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
21553000 USD
CY2013Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
175000000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
0 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
11496000 USD
CY2012Q2 us-gaap Profit Loss
ProfitLoss
-10245000 USD
us-gaap Profit Loss
ProfitLoss
-39115000 USD
CY2013Q2 us-gaap Profit Loss
ProfitLoss
-4353000 USD
us-gaap Profit Loss
ProfitLoss
-18854000 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16577000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16526000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19467000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9321000 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9557000 USD
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4490000 USD
us-gaap Restructuring Charges
RestructuringCharges
2109000 USD
us-gaap Restructuring Charges
RestructuringCharges
3921000 USD
CY2012Q2 us-gaap Restructuring Charges
RestructuringCharges
965000 USD
CY2013Q2 us-gaap Restructuring Charges
RestructuringCharges
2577000 USD
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-426379000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-388770000 USD
CY2013Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
200000 USD
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
400000 USD
CY2012Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
100000 USD
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
200000 USD
us-gaap Revenues From Transactions With Other Operating Segments Of Same Entity
RevenuesFromTransactionsWithOtherOperatingSegmentsOfSameEntity
0 USD
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
9917000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
18556000 USD
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
18618000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
34145000 USD
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
23821000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
18988000 USD
CY2012Q2 us-gaap Sales Revenue Net
SalesRevenueNet
10211000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
55197000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10106000 USD
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13879000 USD
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5435000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
26303000 USD
CY2013Q1 us-gaap Senior Notes
SeniorNotes
175000000.0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2169000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
7003000 USD
CY2013Q2 us-gaap Share Price
SharePrice
7.03
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
24386000 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
928000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
179386000 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
314482000 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
178894000 USD
CY2013Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
312484000 USD
opk Fair Value Of Contingent Consideration Period Increase
FairValueOfContingentConsiderationPeriodIncrease
3921000 USD
CY2013Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
CY2012Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
24386000 USD
CY2013Q2 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
0 USD
CY2012Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
30595000 USD
CY2012Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
2000000 shares
CY2013Q2 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
2000000 shares
CY2012Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
1129032 shares
CY2013Q2 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0 shares
CY2012Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1129032 shares
CY2013Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2013Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
2293056 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2293056 shares
CY2013Q2 us-gaap Treasury Stock Value
TreasuryStockValue
7457000 USD
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
7457000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of estimates</font><font style="font-family:inherit;font-size:10pt;">. The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div></div>
CY2013Q2 us-gaap Variable Interest Entity Consolidated Carrying Amount Assets
VariableInterestEntityConsolidatedCarryingAmountAssets
6000000 USD
CY2012Q4 us-gaap Variable Interest Entity Consolidated Carrying Amount Assets
VariableInterestEntityConsolidatedCarryingAmountAssets
5600000 USD
CY2013Q2 us-gaap Variable Interest Entity Consolidated Carrying Amount Liabilities
VariableInterestEntityConsolidatedCarryingAmountLiabilities
7800000 USD
CY2012Q4 us-gaap Variable Interest Entity Consolidated Carrying Amount Liabilities
VariableInterestEntityConsolidatedCarryingAmountLiabilities
5500000 USD
CY2013Q2 opk Accounts Receivable From Major Customer
AccountsReceivableFromMajorCustomer
0.10
CY2012Q4 opk Accounts Receivable From Major Customer
AccountsReceivableFromMajorCustomer
0.10
CY2012Q4 opk Accrued Clinical Trials
AccruedClinicalTrials
50000 USD
CY2013Q2 opk Accrued Clinical Trials
AccruedClinicalTrials
315000 USD
CY2009Q3 opk Additional Investment By Group Of Investor
AdditionalInvestmentByGroupOfInvestor
5000000 USD
CY2009Q3 opk Agreement Pursuant To Which Invested
AgreementPursuantToWhichInvested
2500000 USD
opk Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration If Estimated Future Sales Decrease
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationIfEstimatedFutureSalesDecrease
500000 USD
opk Common Stock Warrants Net Exercised
CommonStockWarrantsNetExercised
815000 USD
opk Common Stock Warrants Net Exercised
CommonStockWarrantsNetExercised
0 USD
CY2013Q1 opk Debt Instrument Conversion Price
DebtInstrumentConversionPrice
7.07
opk Debt Instrument Conversion Price
DebtInstrumentConversionPrice
7.07
CY2013Q1 opk Debt Instrument Convertible Maturity Date
DebtInstrumentConvertibleMaturityDate
2033-02-01
opk Debt Instrument Convertible Maturity Date
DebtInstrumentConvertibleMaturityDate
2033-02-01
opk Debt Instrument Expected Stock Volatility Rate
DebtInstrumentExpectedStockVolatilityRate
0.35
CY2013Q1 opk Debt Instrument Expected Stock Volatility Rate
DebtInstrumentExpectedStockVolatilityRate
0.40
opk Debt Instrument Percentage Of Conversion Price
DebtInstrumentPercentageOfConversionPrice
1.3
CY2013Q2 opk Debt Instrument Principal Amount For Conversion
DebtInstrumentPrincipalAmountForConversion
1000 USD
opk Debt Instrument Redemption Period Description
DebtInstrumentRedemptionPeriodDescription
On or after February 1, 2017 and before February 1, 2019
opk Debt Instrument Redemption Price As Percentage Of Principal Amount
DebtInstrumentRedemptionPriceAsPercentageOfPrincipalAmount
1.00
CY2012Q4 opk Deferred Acquisition Payments Net Of Discount
DeferredAcquisitionPaymentsNetOfDiscount
6172000 USD
CY2013Q2 opk Deferred Acquisition Payments Net Of Discount
DeferredAcquisitionPaymentsNetOfDiscount
5432000 USD
CY2013Q2 opk Deferred Acquisition Payments Net Of Discount Long Term Liabilities
DeferredAcquisitionPaymentsNetOfDiscountLongTermLiabilities
3983000 USD
CY2012Q4 opk Deferred Acquisition Payments Net Of Discount Long Term Liabilities
DeferredAcquisitionPaymentsNetOfDiscountLongTermLiabilities
3931000 USD
CY2013Q2 opk Deferred Revenue Related To Other Revenues
DeferredRevenueRelatedToOtherRevenues
6000000 USD
CY2012Q4 opk Deferred Revenue Related To Other Revenues
DeferredRevenueRelatedToOtherRevenues
1900000 USD
CY2013Q2 opk Effect Of Loss On Foreign Currency Derivative Before Tax
EffectOfLossOnForeignCurrencyDerivativeBeforeTax
-133000 USD
CY2012Q4 opk Effect Of Loss On Foreign Currency Derivative Before Tax
EffectOfLossOnForeignCurrencyDerivativeBeforeTax
10000 USD
CY2013Q1 opk Estimated Fair Value Of Embedded Derivatives
EstimatedFairValueOfEmbeddedDerivatives
59204000 USD
opk Estimated Fair Value Of Embedded Derivatives
EstimatedFairValueOfEmbeddedDerivatives
74079000 USD
opk Exercise Of Common Warrant
ExerciseOfCommonWarrant
-591000 USD
opk Fair Value Of Contingent Consideration Period Increase
FairValueOfContingentConsiderationPeriodIncrease
2109000 USD
CY2013Q1 opk Fair Value Of Notes Without Embedded Derivative
FairValueOfNotesWithoutEmbeddedDerivative
115796000 USD
CY2013Q2 opk Finite Lived Research And Development In Process
FiniteLivedResearchAndDevelopmentInProcess
203052000 USD
CY2012Q4 opk Finite Lived Research And Development In Process
FiniteLivedResearchAndDevelopmentInProcess
11546000 USD
CY2013Q1 opk Fair Value Of Notes With Embedded Derivative
FairValueOfNotesWithEmbeddedDerivative
175000000 USD
opk Fair Value Of Notes With Embedded Derivative
FairValueOfNotesWithEmbeddedDerivative
189481000 USD
opk Fair Value Of Notes Without Embedded Derivative
FairValueOfNotesWithoutEmbeddedDerivative
115402000 USD
CY2009Q3 opk First Installment Investment
FirstInstallmentInvestment
2500000 USD
CY2012Q1 opk Fund For Research Agreement
FundForResearchAgreement
900000 USD
CY2012Q2 opk Gain Loss From Continuing Operations Before Investment Losses
GainLossFromContinuingOperationsBeforeInvestmentLosses
-9770000 USD
CY2013Q2 opk Gain Loss From Continuing Operations Before Investment Losses
GainLossFromContinuingOperationsBeforeInvestmentLosses
-1982000 USD
opk Gain Loss From Continuing Operations Before Investment Losses
GainLossFromContinuingOperationsBeforeInvestmentLosses
-17858000 USD
opk Gain Loss From Continuing Operations Before Investment Losses
GainLossFromContinuingOperationsBeforeInvestmentLosses
-32854000 USD
CY2013Q2 opk Gross Unrealized Gains Included In Accumulated Other Comprehensive Income Loss
GrossUnrealizedGainsIncludedInAccumulatedOtherComprehensiveIncomeLoss
1396000 USD
CY2012Q4 opk Gross Unrealized Gains Included In Accumulated Other Comprehensive Income Loss
GrossUnrealizedGainsIncludedInAccumulatedOtherComprehensiveIncomeLoss
4160000 USD
opk Gross Unrealized Gains Included In Other Comprehensive Income Loss
GrossUnrealizedGainsIncludedInOtherComprehensiveIncomeLoss
-2764000 USD
opk Gross Unrealized Gains Included In Other Comprehensive Income Loss Before Reclassification Net Of Tax
GrossUnrealizedGainsIncludedInOtherComprehensiveIncomeLossBeforeReclassificationNetOfTax
1829000 USD
opk Gross Unrealized Gains Included In Other Comprehensive Income Loss Reclassification Net Of Tax
GrossUnrealizedGainsIncludedInOtherComprehensiveIncomeLossReclassificationNetOfTax
-4593000 USD
opk Increase Decrease In Foreign Currency Measurement
IncreaseDecreaseInForeignCurrencyMeasurement
-109000 USD
opk Increase Decrease In Foreign Currency Measurement
IncreaseDecreaseInForeignCurrencyMeasurement
450000 USD
opk License Revenue
LicenseRevenue
14800000 USD
opk Long Term Investments Maturities Period Minimum
LongTermInvestmentsMaturitiesPeriodMinimum
P1Y
CY2012Q4 opk Loss Contingency Recovery Of Compensatory Damages
LossContingencyRecoveryOfCompensatoryDamages
20000000 USD
opk Maximum Number Of Days Interest Bearing Instruments With Original Maturities To Consider As Cash Equivalent
MaximumNumberOfDaysInterestBearingInstrumentsWithOriginalMaturitiesToConsiderAsCashEquivalent
P90D
opk Maximum Number Of Days Interest Bearing Instruments With Remaining Maturities To Consider As Marketable Securities
MaximumNumberOfDaysInterestBearingInstrumentsWithRemainingMaturitiesToConsiderAsMarketableSecurities
P90D
CY2013Q2 opk Mortgages And Other Debts Payable
MortgagesAndOtherDebtsPayable
3636000 USD
CY2012Q4 opk Mortgages And Other Debts Payable
MortgagesAndOtherDebtsPayable
5150000 USD
opk Number Of Common Stock Issued For Stock Warrant And Stock Options Exercised
NumberOfCommonStockIssuedForStockWarrantAndStockOptionsExercised
1612232 shares
CY2013Q2 opk Number Of Common Stock Warrant And Common Stock Options Exercised
NumberOfCommonStockWarrantAndCommonStockOptionsExercised
216053 shares
opk Number Of Common Stock Warrant And Common Stock Options Exercised
NumberOfCommonStockWarrantAndCommonStockOptionsExercised
1727746 shares
CY2009Q3 opk Number Of Convertible Series Preferred Stock Held From Agreement
NumberOfConvertibleSeriesPreferredStockHeldFromAgreement
1701723 shares
CY2013Q2 opk Number Of Customer Representation
NumberOfCustomerRepresentation
0 Customer
opk Number Of Customer Representation
NumberOfCustomerRepresentation
0 Customer
opk Number Of Customer Representation
NumberOfCustomerRepresentation
0 Customer
CY2013Q2 opk Number Of Customer Representation
NumberOfCustomerRepresentation
0 Customer
CY2012Q2 opk Number Of Customer Representation
NumberOfCustomerRepresentation
0 Customer
CY2012Q4 opk Number Of Customer Representation
NumberOfCustomerRepresentation
0 Customer
opk Number Of Days In Consecutive Trading Period For Redemption
NumberOfDaysInConsecutiveTradingPeriodForRedemption
P30D
CY2009Q3 opk Number Of Equal Installments Payable For Additional Investment
NumberOfEqualInstallmentsPayableForAdditionalInvestment
2 Installment
opk Number Of Minimum Trading Days Applicable For Conversion Price
NumberOfMinimumTradingDaysApplicableForConversionPrice
P20D
CY2012Q3 opk Numberof Medicare Claims Includedin Post Payment Review Audit
NumberofMedicareClaimsIncludedinPostPaymentReviewAudit
183 claim
opk Other Comprehensive Income Loss Foreign Currency Transactionand Translation Reclassification Adjustmentfrom Aoci Realizedupon Saleor Liquidation Netof Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionandTranslationReclassificationAdjustmentfromAOCIRealizeduponSaleorLiquidationNetofTax
0 USD
opk Percentage Of Customer In Revenue
PercentageOfCustomerInRevenue
0.10
opk Percentage Of Customer In Revenue
PercentageOfCustomerInRevenue
0.10
CY2012Q2 opk Percentage Of Customer In Revenue
PercentageOfCustomerInRevenue
0.10
CY2013Q2 opk Percentage Of Customer In Revenue
PercentageOfCustomerInRevenue
0.10
opk Percentage Of Increase Decrease In Discount Rate
PercentageOfIncreaseDecreaseInDiscountRate
0.01
opk Provision For Reversal Of Inventory Reserves
ProvisionForReversalOfInventoryReserves
754000 USD
opk Provision For Reversal Of Inventory Reserves
ProvisionForReversalOfInventoryReserves
1273000 USD
opk Provision Recovery Of For Doubtful Accounts
ProvisionRecoveryOfForDoubtfulAccounts
329000 USD
CY2013Q2 opk Proceedstobereceivedfromsaleofproprietarytechnology
Proceedstobereceivedfromsaleofproprietarytechnology
265000000 RUB
CY2013Q2 opk Percentage Of Increase Decrease In Future Sales
PercentageOfIncreaseDecreaseInFutureSales
-0.1
opk Percentageof Shareholdingby Chairmanof Acquiree Company
PercentageofShareholdingbyChairmanofAcquireeCompany
0.05
opk Percentageof Shareholdingby Directorsof Acquiree Company
PercentageofShareholdingbyDirectorsofAcquireeCompany
0.05
CY2009Q3 opk Previous Investment By Group Of Investor
PreviousInvestmentByGroupOfInvestor
5000000 USD
CY2013Q2 opk Proceedstobereceivedfromsaleofproprietarytechnology
Proceedstobereceivedfromsaleofproprietarytechnology
8100000 USD
opk Provision Recovery Of For Doubtful Accounts
ProvisionRecoveryOfForDoubtfulAccounts
-91000 USD
CY2012Q2 opk Reimbursement Paid To Related Party For Travel
ReimbursementPaidToRelatedPartyForTravel
65000 USD
CY2013Q2 opk Reimbursement Paid To Related Party For Travel
ReimbursementPaidToRelatedPartyForTravel
5000 USD
opk Reimbursement Paid To Related Party For Travel
ReimbursementPaidToRelatedPartyForTravel
18000 USD
opk Reimbursement Paid To Related Party For Travel
ReimbursementPaidToRelatedPartyForTravel
129000 USD
opk Repayments Of Lines Of Credit And Capital Lease Obligations
RepaymentsOfLinesOfCreditAndCapitalLeaseObligations
16288000 USD
opk Repayments Of Lines Of Credit And Capital Lease Obligations
RepaymentsOfLinesOfCreditAndCapitalLeaseObligations
17718000 USD
CY2012Q1 opk Research Agreement Maturity Period
ResearchAgreementMaturityPeriod
P5Y
CY2010Q2 opk Researchand Development Agreement Amountfor Period
ResearchandDevelopmentAgreementAmountforPeriod
200000 USD
opk Revenue From Receipt Of Equity
RevenueFromReceiptOfEquity
12620000 USD
opk Revenue From Receipt Of Equity
RevenueFromReceiptOfEquity
102000 USD
opk Shares Surrendered In Lieu Of Cash Payment
SharesSurrenderedInLieuOfCashPayment
115514 shares
opk Short Term Investments Maturities Period Maximum
ShortTermInvestmentsMaturitiesPeriodMaximum
P1Y
opk Short Term Investments Maturities Period Minimum
ShortTermInvestmentsMaturitiesPeriodMinimum
P90D
CY2013Q2 opk Unrealized Gain On Investments Options And Warrants
UnrealizedGainOnInvestmentsOptionsAndWarrants
3671000 USD
CY2013Q2 opk Variable Interest Entity Entity Accumulated Losses In Investees
VariableInterestEntityEntityAccumulatedLossesInInvestees
10979000 USD
CY2012Q2 opk Variable Interest Entity Ownership Amount
VariableInterestEntityOwnershipAmount
700000 USD
CY2011Q3 opk Warrants Expiration Period
WarrantsExpirationPeriod
P2Y
opk Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
297689886 shares
CY2012Q2 opk Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
297836707 shares
CY2013Q2 opk Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
336732215 shares
opk Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
324898133 shares
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000944809
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
336811725 shares
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Opko Health, Inc.
CY2011Q3 invest Investment Warrants Exercise Price
InvestmentWarrantsExercisePrice
1.25

Files In Submission

Name View Source Status
0000944809-13-000007-index-headers.html Edgar Link pending
0000944809-13-000007-index.html Edgar Link pending
0000944809-13-000007.txt Edgar Link pending
0000944809-13-000007-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
opk-20130630.xml Edgar Link completed
opk-20130630.xsd Edgar Link pending
opk-20130630_cal.xml Edgar Link unprocessable
opk-20130630_def.xml Edgar Link unprocessable
opk-20130630_lab.xml Edgar Link unprocessable
opk-20130630_pre.xml Edgar Link unprocessable
opk-6302013x10q.htm Edgar Link pending
opk-6302013xex311.htm Edgar Link pending
opk-6302013xex312.htm Edgar Link pending
opk-6302013xex321.htm Edgar Link pending
opk-6302013xex322.htm Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R39.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R40.xml Edgar Link unprocessable
R41.htm Edgar Link pending
R41.xml Edgar Link unprocessable
R42.htm Edgar Link pending
R42.xml Edgar Link unprocessable
R43.htm Edgar Link pending
R43.xml Edgar Link unprocessable
R44.htm Edgar Link pending
R44.xml Edgar Link unprocessable
R45.htm Edgar Link pending
R45.xml Edgar Link unprocessable
R46.htm Edgar Link pending
R46.xml Edgar Link unprocessable
R47.htm Edgar Link pending
R47.xml Edgar Link unprocessable
R48.htm Edgar Link pending
R48.xml Edgar Link unprocessable
R49.htm Edgar Link pending
R49.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R50.htm Edgar Link pending
R50.xml Edgar Link unprocessable
R51.htm Edgar Link pending
R51.xml Edgar Link unprocessable
R52.htm Edgar Link pending
R52.xml Edgar Link unprocessable
R53.htm Edgar Link pending
R53.xml Edgar Link unprocessable
R54.htm Edgar Link pending
R54.xml Edgar Link unprocessable
R55.htm Edgar Link pending
R55.xml Edgar Link unprocessable
R56.htm Edgar Link pending
R56.xml Edgar Link unprocessable
R57.htm Edgar Link pending
R57.xml Edgar Link unprocessable
R58.htm Edgar Link pending
R58.xml Edgar Link unprocessable
R59.htm Edgar Link pending
R59.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R60.htm Edgar Link pending
R60.xml Edgar Link unprocessable
R61.htm Edgar Link pending
R61.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending